Your browser doesn't support javascript.
loading
Phase 1 clinical trial evaluating abatacept in patients with steroid-refractory chronic graft-versus-host disease.
Nahas, Myrna R; Soiffer, Robert J; Kim, Haesook T; Alyea, Edwin P; Arnason, Jon; Joyce, Robin; Antin, Joseph H; Ho, Vincent T; Stroopinsky, Dina; Li, Shuli; Levine, James D; McMasters, Malgorzata; Jain, Salvia; Hamdan, Ayad; Tzachanis, Dimitrios; Bryant, Mary Paty; Logan, Emma K; Bazemore, Josie; Stewart, Jeremy; Joyce, Amy; Stephenson, Susan; Washington, Abigail; Cole, Leandra; Pyzer, Athalia; Leaf, Rebecca Karp; Avigan, David E; Rosenblatt, Jacalyn.
Afiliación
  • Nahas MR; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.
  • Soiffer RJ; Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and.
  • Kim HT; Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and.
  • Alyea EP; Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and.
  • Arnason J; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.
  • Joyce R; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.
  • Antin JH; Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and.
  • Ho VT; Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and.
  • Stroopinsky D; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.
  • Li S; Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and.
  • Levine JD; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.
  • McMasters M; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.
  • Jain S; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.
  • Hamdan A; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.
  • Tzachanis D; Blood and Marrow Transplant Program, University of California, San Diego, La Jolla, CA.
  • Bryant MP; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.
  • Logan EK; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.
  • Bazemore J; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.
  • Stewart J; Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and.
  • Joyce A; Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and.
  • Stephenson S; Hematologic Malignancies, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA; and.
  • Washington A; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.
  • Cole L; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.
  • Pyzer A; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.
  • Leaf RK; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.
  • Avigan DE; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.
  • Rosenblatt J; Section of Hematological Malignancies and Bone Marrow Transplantation, Beth Israel Deaconess Medical Center, and.
Blood ; 131(25): 2836-2845, 2018 06 21.
Article en En | MEDLINE | ID: mdl-29549175

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfocitos T / Abatacept / Enfermedad Injerto contra Huésped / Inmunosupresores Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2018 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Linfocitos T / Abatacept / Enfermedad Injerto contra Huésped / Inmunosupresores Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Blood Año: 2018 Tipo del documento: Article